HUTCHMED (China) (HCM) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $13.94, +3.41% vs the prior close of $13.48.
- Volume 51.90K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
HCM jumps 3.4% to $13.94. Closed at $13.94, +3.41% vs the prior close of $13.48. Day range $13.52–$13.95, opened at $13.52.
HCM daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — HCM jumps 3.4% to $13.94
- Closed at $13.94, +3.41% vs the prior close of $13.48. Day range $13.52–$13.95, opened at $13.52.
- Volume was 51.90K shares, 0.7x its 50-day average of 74.60K.
- Price is +4.9% vs its 50-day average ($13.29) and +5.3% vs its 200-day average ($13.24).
- 52-week range $9.77–$16.33; today's close sits at 64% of that range, 14.6% below the 52-week high.
Oct 14, 2026 — HCM ends flat (-0.1%) to $13.48, 3 down days in a row
- Closed at $13.48, -0.15% vs the prior close of $13.50. Day range $13.47–$13.99, opened at $13.51.
- Volume was 81.80K shares, 1.1x its 50-day average of 73.22K.
- Price is +1.8% vs its 50-day average ($13.24) and +1.9% vs its 200-day average ($13.23).
- 52-week range $9.77–$16.33; today's close sits at 57% of that range, 17.5% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — HCM dips 1.3% to $13.50
- Closed at $13.50, -1.32% vs the prior close of $13.68. Day range $13.28–$13.58, opened at $13.52.
- Volume was 37.00K shares, 0.5x its 50-day average of 74.12K — lighter than usual.
- Price is +2.2% vs its 50-day average ($13.21) and +2.0% vs its 200-day average ($13.24).
- 52-week range $9.77–$16.33; today's close sits at 57% of that range, 17.3% below the 52-week high.
Oct 12, 2026 — HCM dips 3.0% to $13.68
- Closed at $13.68, -2.98% vs the prior close of $14.10. Day range $13.58–$14.00, opened at $14.00.
- Volume was 43.80K shares, 0.6x its 50-day average of 74.02K — lighter than usual.
- Price is +3.9% vs its 50-day average ($13.17) and +3.4% vs its 200-day average ($13.24).
- 52-week range $9.77–$16.33; today's close sits at 60% of that range, 16.2% below the 52-week high.
Oct 9, 2026 — HCM jumps 3.1% to $14.10
- Closed at $14.10, +3.15% vs the prior close of $13.67. Day range $13.74–$14.10, opened at $13.74.
- Volume was 50.10K shares, 0.7x its 50-day average of 74.21K.
- Price is +7.5% vs its 50-day average ($13.12) and +6.5% vs its 200-day average ($13.23).
- 52-week range $9.77–$16.33; today's close sits at 66% of that range, 13.7% below the 52-week high.
Oct 8, 2026 — HCM slides 4.3% to $13.67
- Closed at $13.67, -4.27% vs the prior close of $14.28. Day range $13.51–$13.87, opened at $13.87.
- Volume was 45.10K shares, 0.6x its 50-day average of 74.17K.
- Price is +4.8% vs its 50-day average ($13.05) and +3.3% vs its 200-day average ($13.23).
- 52-week range $9.77–$16.40; today's close sits at 59% of that range, 16.6% below the 52-week high.
Oct 7, 2026 — HCM dips 2.2% to $14.28
- Closed at $14.28, -2.19% vs the prior close of $14.60. Day range $14.06–$14.35, opened at $14.29.
- Volume was 58.00K shares, 0.8x its 50-day average of 73.57K.
- Price is +9.8% vs its 50-day average ($13.00) and +7.9% vs its 200-day average ($13.23).
- 52-week range $9.77–$16.40; today's close sits at 68% of that range, 12.9% below the 52-week high.
Oct 6, 2026 — HCM rises 2.0% to $14.60
- Closed at $14.60, +2.03% vs the prior close of $14.31. Day range $14.54–$14.74, opened at $14.55.
- Volume was 68.50K shares, 0.9x its 50-day average of 73.00K.
- Price is +12.8% vs its 50-day average ($12.94) and +10.4% vs its 200-day average ($13.22).
- 52-week range $9.77–$16.40; today's close sits at 73% of that range, 11.0% below the 52-week high.
Oct 5, 2026 — HCM rises 0.8% to $14.31
- Closed at $14.31, +0.77% vs the prior close of $14.20. Day range $13.90–$14.34, opened at $14.14.
- Volume was 65.10K shares, 0.9x its 50-day average of 72.71K.
- Price is +11.2% vs its 50-day average ($12.87) and +8.3% vs its 200-day average ($13.22).
- 52-week range $9.77–$16.40; today's close sits at 68% of that range, 12.7% below the 52-week high.
Oct 2, 2026 — HCM dips 2.5% to $14.20
- Closed at $14.20, -2.54% vs the prior close of $14.57. Day range $14.10–$14.34, opened at $14.31.
- Volume was 45.70K shares, 0.6x its 50-day average of 72.71K.
- Price is +10.9% vs its 50-day average ($12.81) and +7.5% vs its 200-day average ($13.21).
- 52-week range $9.77–$16.40; today's close sits at 67% of that range, 13.4% below the 52-week high.
HCM latest news & SEC filings
Every SEC filing by or about HCM in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 29, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 24, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 3, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 31, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 28, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 18, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 17, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 30, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 2, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 30, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 29, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 25, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade HCM
- How much it moves: over the last 20 sessions the average daily move was 2.18% (largest 5.9%).
- Liquidity: about 58.58K shares (≈$816.61K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $13.94 vs a range of $9.77–$16.33 (64% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Sep 29, 2026; 6-K Sep 29, 2026; 6-K Sep 24, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
HCM market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 13.52 | 13.95 | 13.52 | 13.94 | 51.90K |
| Oct 14, 2026 | 13.51 | 13.99 | 13.47 | 13.48 | 81.80K |
| Oct 13, 2026 | 13.52 | 13.58 | 13.28 | 13.50 | 37.00K |
| Oct 12, 2026 | 14.00 | 14.00 | 13.58 | 13.68 | 43.80K |
| Oct 9, 2026 | 13.74 | 14.10 | 13.74 | 14.10 | 50.10K |
| Oct 8, 2026 | 13.87 | 13.87 | 13.51 | 13.67 | 45.10K |
| Oct 7, 2026 | 14.29 | 14.35 | 14.06 | 14.28 | 58.00K |
| Oct 6, 2026 | 14.55 | 14.74 | 14.54 | 14.60 | 68.50K |
| Oct 5, 2026 | 14.14 | 14.34 | 13.90 | 14.31 | 65.10K |
| Oct 2, 2026 | 14.31 | 14.34 | 14.10 | 14.20 | 45.70K |
| Oct 1, 2026 | 14.63 | 14.80 | 14.57 | 14.57 | 71.00K |
| Sep 30, 2026 | 14.45 | 14.93 | 14.45 | 14.63 | 78.10K |
| Sep 29, 2026 | 14.19 | 14.29 | 14.03 | 14.15 | 46.20K |
| Sep 28, 2026 | 13.93 | 14.22 | 13.93 | 14.13 | 29.70K |
| Sep 25, 2026 | 14.06 | 14.14 | 13.91 | 13.94 | 71.30K |
| Sep 24, 2026 | 13.97 | 14.08 | 13.81 | 13.90 | 44.30K |
| Sep 23, 2026 | 14.13 | 14.43 | 14.10 | 14.37 | 117.60K |
| Sep 22, 2026 | 14.17 | 14.23 | 14.01 | 14.07 | 37.00K |
| Sep 21, 2026 | 14.06 | 14.55 | 14.06 | 14.48 | 113.60K |
| Sep 18, 2026 | 13.68 | 13.77 | 13.57 | 13.67 | 15.80K |
About HUTCHMED (China)
HUTCHMED (China) (HCM) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in HONG KONG. State of incorporation: Cayman Islands. Fiscal year ends —. SEC CIK 1648257.
HCM board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Renu Bhatia | Director | Mar 10, 2026 |
| Chig Fung Cheng | Acting CEO and CFO | May 21, 2026 |
| Dan Eldar | Director | Mar 10, 2026 |
| Chaohong Hu | Director | Mar 10, 2026 |
| Edith Shih | Director | Mar 10, 2026 |
| Wei-Guo Su | CEO and CSO | May 21, 2026 |
| Daniel Shao Weng Tan | Director | Mar 10, 2026 |
| Tak Wai Wong | Director | Mar 10, 2026 |
| Ling Yang | Director | Mar 10, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Chig Fung Cheng | Acting CEO and CFO | May 21, 2026 |
| Lorenso Chiu | Deputy Chief Financial Officer | May 21, 2026 |
| Charles George Rupert Nixon | Group General Counsel | May 21, 2026 |
| Wei-Guo Su | CEO and CSO | May 21, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
HCM financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
HCM earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on HCM
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.